Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MIMEDX GROUP, INC.MDXG · Entity 5271 | SVP, Operations & Procurement | May 02, 2022 | May 04, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MIMEDX GROUP, INC.
Report date May 02, 2022 · Filed May 04, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 226,643 |
Reported balance
After 2022-05-02 transaction · row 1
1 source rowRow 1 · 2022-05-02 · Sale · Disposed 5,260 · Balance 226,643 F1: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. F2: The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $3.999 to $4.01, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.
F2: The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $3.999 to $4.01, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 02, 2022 Filed May 4, 2022 16:33 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 5,260 | $4.00 | $21,045.26 |
DisclosureSEC source: 0001376339-22-000062 · wf-form4_165169631789193.xml · nonDerivative · entry 1 Turner Scott M · CIK 0001761796 · SVP, Operations & Procurement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,643 F1 · kind: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. F2 · price: The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $3.999 to $4.01, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 17:28 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 61,472 | $4.62 | $284,000.64 |
DisclosureSEC source: 0001376339-22-000042 · wf-form4_164979887022093.xml · nonDerivative · entry 1 Turner Scott M · CIK 0001761796 · SVP, Operations & Procurement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,903 F1 · shares: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years. Grant is exempt under Rule 16b-3. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 16:29 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 4,155 | $4.86 | $20,189.15 |
DisclosureSEC source: 0001376339-22-000026 · wf-form4_164694778126649.xml · nonDerivative · entry 1 Turner Scott M · CIK 0001761796 · SVP, Operations & Procurement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,431 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. F2 · price: The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $4.75 to $4.965, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 17:08 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 5,738 | $4.50 | $25,821.00 |
DisclosureSEC source: 0001761796-22-000002 · wf-form4_164582689062570.xml · nonDerivative · entry 1 Turner Scott M · CIK 0001761796 · SVP, Operations & Procurement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,586 F1 · kind: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. F2 · price: The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $4.50 to $4.51, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| April 26, 2021 Filed Apr 27, 2021 16:32 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 5,224 | $10.63 | $55,531.12 |
DisclosureSEC source: 0001761796-21-000008 · wf-form4_161955548285835.xml · nonDerivative · entry 1 Turner Scott M · CIK 0001761796 · SVP, Operations & Procurement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,324 F1 · kind: This transaction represents the netting of shares to pay applicable withholing upon vesting of previously-granted restricted stock. Read SEC document |
| March 04, 2021 Filed Mar 8, 2021 16:26 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 39,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001761796-21-000006 · wf-form4_161523874777070.xml · nonDerivative · entry 1 Turner Scott M · CIK 0001761796 · SVP, Operations & Procurement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,548 F1 · shares: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years. Read SEC document |
| February 22, 2021 Filed Feb 23, 2021 14:41 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 1,572 | $9.98 | $15,688.56 |
DisclosureSEC source: 0001761796-21-000004 · wf-form4_161410927689618.xml · nonDerivative · entry 1 Turner Scott M · CIK 0001761796 · SVP, Operations & Procurement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,827 F1 · kind: This transaction represents the netting of shares to satisfy applicable witholding taxes upon the vesting of previously-granted restricted stock. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 14:35 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 5,278 | $9.81 | $51,777.18 |
DisclosureSEC source: 0001761796-21-000002 · wf-form4_161402250386074.xml · nonDerivative · entry 1 Turner Scott M · CIK 0001761796 · SVP, Operations & Procurement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,399 F1 · kind: This transaction represents the netting of shares to satisfy applicable witholding taxes upon the vesting of previously-granted restricted stock. Read SEC document |
| October 26, 2020 Filed Oct 28, 2020 08:46 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 301 | $5.91 | $1,778.91 |
DisclosureSEC source: 0001376339-20-000139 · wf-form4_160388917315375.xml · nonDerivative · entry 1 Turner Scott M · CIK 0001761796 · SVP, Operations & Procurement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,677 F1 · kind: Represents shares withheld to pay applicable withholding taxes upon vesting. Read SEC document |
| August 05, 2020 Filed Aug 6, 2020 16:46 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 48,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001761796-20-000002 · wf-form4_159674679065492.xml · nonDerivative · entry 1 Turner Scott M · CIK 0001761796 · SVP, Operations & Procurement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,978 F1 · price: On August 5, 2020, the Company fixed the number of shares subject to previously-awarded restricted units based on the closing stock price on that date ($5.90). Award will be settled in common stock upon vesting. One-third of the award vests upon each anniversary of the original grant date, February 18, 2020. Grant is exempt under rule 16b-3. Read SEC document |
| April 26, 2020 Filed Apr 27, 2020 16:32 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 5,067 | $3.79 | $19,203.93 |
DisclosureSEC source: 0001376339-20-000025 · wf-form4_158801950630721.xml · nonDerivative · entry 1 Turner Scott M · CIK 0001761796 · SVP, Operations & Procurement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,843 F1 · kind: This transaction represents the netting of shares to satisfy applicable witholding taxes upon the vesting of previously-granted restricted stock. Read SEC document |
| February 22, 2020 Filed Feb 24, 2020 16:26 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 1,629 | $7.54 | $12,282.66 |
DisclosureSEC source: 0001376339-20-000004 · wf-form4_158257954460210.xml · nonDerivative · entry 2 Turner Scott M · CIK 0001761796 · SVP, Operations & Procurement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,910 F1 · kind: This transaction represents the netting of shares to satisfy applicable witholding taxes upon the vesting of previously-granted restricted stock. Read SEC document |
| February 22, 2020 Filed Feb 24, 2020 16:26 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 3,540 | $7.54 | $26,691.60 |
DisclosureSEC source: 0001376339-20-000004 · wf-form4_158257954460210.xml · nonDerivative · entry 1 Turner Scott M · CIK 0001761796 · SVP, Operations & Procurement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,539 F1 · kind: This transaction represents the netting of shares to satisfy applicable witholding taxes upon the vesting of previously-granted restricted stock. Read SEC document |
| October 26, 2019 Filed Oct 29, 2019 16:58 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 292 | $5.05 | $1,474.60 |
DisclosureSEC source: 0001376339-19-000039 · wf-form4_157238265846924.xml · nonDerivative · entry 1 Turner Scott M · CIK 0001761796 · SVP, Operations & Procurement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,079 F1 · kind: This transaction represents the netting of shares to satisfy applicable witholding taxes upon the vesting of previously-granted restricted stock. Read SEC document |
| April 26, 2019 Filed Apr 29, 2019 16:06 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 52,067 | $2.41 | $125,481.47 |
DisclosureSEC source: 0001376339-19-000015 · wf-form4_155656837735093.xml · nonDerivative · entry 2 Turner Scott M · CIK 0001761796 · SVP, Operations & Procurement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,371 F2 · kind: Represents Restricted Stock Award granted on April 26, 2019, in accordance with the Company's annual grant process, under which restricted shares shall vest pursuant to the Company's standard vesting schedule of 1/3 of shares vesting on each of the first, second and third anniversary dates of the grant date of the Restricted Stock Award. Read SEC document |
| April 25, 2019 Filed Apr 29, 2019 16:06 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 1,460 | $2.45 | $3,577.00 |
DisclosureSEC source: 0001376339-19-000015 · wf-form4_155656837735093.xml · nonDerivative · entry 1 Turner Scott M · CIK 0001761796 · SVP, Operations & Procurement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,304 F1 · kind: This transaction represents the netting of shares to satisfy applicable witholding taxes upon the vesting of previously-granted restricted stock. Read SEC document |
| February 22, 2019 Filed Feb 25, 2019 16:22 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 1,876 | $3.15 | $5,909.40 |
DisclosureSEC source: 0001376339-19-000012 · wf-form4_155112975758422.xml · nonDerivative · entry 2 Turner Scott M · CIK 0001761796 · SVP, Operations & Procurement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,764 F1 · shares: This transaction represents the netting of shares to satisfy applicable witholding taxes upon the vesting of previously-granted restricted stock. Read SEC document |
| February 22, 2019 Filed Feb 25, 2019 16:22 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 3,540 | $3.15 | $11,151.00 |
DisclosureSEC source: 0001376339-19-000012 · wf-form4_155112975758422.xml · nonDerivative · entry 1 Turner Scott M · CIK 0001761796 · SVP, Operations & Procurement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,640 F1 · shares: This transaction represents the netting of shares to satisfy applicable witholding taxes upon the vesting of previously-granted restricted stock. Read SEC document |
| December 11, 2018 Filed Dec 13, 2018 17:02 UTC Amendment | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 10,000 | $1.54 | $15,400.00 |
DisclosureSEC source: 0001761796-18-000006 · wf-form4a_154473855946221.xml · nonDerivative · entry 1 Turner Scott M · CIK 0001761796 · SVP, Operations & Procurement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,180 F1 · shares: This amendment is filed to correct the number of shares acquired. F2 · balance_after: This includes 54,067 shares of unvested restricted stock. Read SEC document |
| December 11, 2018 Filed Dec 13, 2018 16:31 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 0 | $1.54 | $0.00 |
DisclosureSEC source: 0001761796-18-000004 · wf-form4_154473665673926.xml · nonDerivative · entry 1 Turner Scott M · CIK 0001761796 · SVP, Operations & Procurement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,180 F1 · balance_after: Includes 54,067 shares of unvested restricted stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.